52 results
S-3
EX-4.3
PASG
Passage Bio Inc
4 Mar 24
Shelf registration
4:09pm
, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise, all such liability being, by the acceptance hereof
8-K
EX-99.2
PASG
Passage Bio Inc
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
are made; you will be solely responsible for your own assessment of the market and our market position; and that you will conduct your own analysis
8-K
EX-99.2
w7qyjao1l93 2hj
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
PRE 14A
u7qmycb0
3 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.2
oqnpu9p765l965m4vcf
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am
8-K
EX-99.2
880jn796nd5lmv
4 Aug 22
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
7:20am
8-K
EX-99.2
vcnm6b1z
16 May 22
Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
7:15am
8-K
1o29c5 ed1pqv04w
11 Feb 22
Passage Bio Presents New Interim Clinical Data for Patients with GM1 Gangliosidosis in Imagine-1 Study at 2022 WORLDSymposium
11:00am
8-K
EX-99.2
li4nr 2i0su710
11 Feb 22
Passage Bio Presents New Interim Clinical Data for Patients with GM1 Gangliosidosis in Imagine-1 Study at 2022 WORLDSymposium
11:00am